Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan

Table 2 The attributable fraction of increased T3

Percentiles		P0–9	P10–24	P25–49	P50–74	P75–89	P90+
Concentration of TCS (ng/mL)		0	0.3	0.54	1.30	4.91	63.65
Share of population that shows the effect (increased T3)	Boys	0	0	0	0	0.000217	0,015093
	Girls	0	0	0	0	0.000102	0.026084
Total number of cases	88,957
Sensitivity analysis
Total number of cases	303,759

ISSN: 1476-069X